CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Sale 10b5-1 | −6,890 | $29.29 | $202K | 7,717 |
| 2026-03-02 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Grant or award · Employee Stock Option (Right to Buy) 10b5-1 | +15,033 | 15,033 | ||
| 2026-03-02 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Grant or award · Restricted Stock Unit Award 10b5-1 | +14,176 | 14,176 | ||
| 2026-03-02 | Nichols Christian Todd SVP, Chief Commercial Officer | Sale 10b5-1 | −6,000 | $30.00 | $180K | 109,769 |
| 2026-03-02 | Nichols Christian Todd SVP, Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) 10b5-1 | +66,430 | 66,430 | ||
| 2026-03-02 | Nichols Christian Todd SVP, Chief Commercial Officer | Grant or award · Restricted Stock Unit Award 10b5-1 | +30,854 | 30,854 | ||
| 2026-03-02 | Jackson Blair Curtis EVP, Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +94,900 | 94,900 | ||
| 2026-03-02 | Jackson Blair Curtis EVP, Chief Operating Officer | Grant or award · Restricted Stock Unit Award | +44,078 | 44,078 | ||
| 2026-03-02 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise 10b5-1 | +5,000 | $19.34 | $97K | 98,389 |
| 2026-03-02 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale 10b5-1 | −9,000 | $29.72 | $267K | 89,389 |
| 2026-03-02 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −5,000 | 21,356 | ||
| 2026-03-02 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) 10b5-1 | +83,037 | 83,037 | ||
| 2026-03-02 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Grant or award · Restricted Stock Unit Award 10b5-1 | +38,568 | 38,568 | ||
| 2026-03-02 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Sale 10b5-1 | −2,034 | $29.29 | $60K | 237,660 |
| 2026-03-02 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Grant or award · Employee Stock Option (Right to Buy) 10b5-1 | +78,292 | 78,292 | ||
| 2026-03-02 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Grant or award · Restricted Stock Unit Award 10b5-1 | +36,364 | 36,364 | ||
| 2026-02-26 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise | +2,747 | 15,415 | ||
| 2026-02-26 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Shares withheld for taxes | −808 | $30.73 | $25K | 14,607 |
| 2026-02-26 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise · Restricted Stock Unit Award | −2,747 | 5,493 | ||
| 2026-02-26 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise | +5,410 | 118,172 |
Page 6 of 41 · 804 trades